EyeBOX
Commercial- Indications
- Concussion, Mild traumatic brain injury
Company intelligence / Profile preview
The EyeBOX device by Oculogica has received FDA clearance as an aid in the diagnosis of concussion. It provides a baseline-free, non-invasive test that objectively measures eye movement abnormalities associated with concussions. The test takes less than four minutes and delivers immediate results to facilitate communication among patients and healthcare providers. Clinical use includes leading institutions such as Midwest Orthopaedics at Rush University and the clinics of the President of the California Brain Injury Association. The company has also received grants from NIH, FDA, and DoD to further develop its technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oculogica.